Plastic bodies in a plastic world: multi-disciplinary approaches to study endocrine disrupting chemicals: We dedicate this manuscript in memory of Dr. Theo Colborn: mentor, colleague and friend

Journal of Cleaner Production

Volumn 140, Issue , 2017, Pages 373-385

  Vandenberg, Laura N ^a   Luthi, Derek ^a   Quinerly, D 'Andre ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Bisphenol A; DOHaD; EDSP; Framework for strategic sustainable development (FSSD); TiPED

Indexed keywords

ANIMALS; CHEMICALS; CONSUMER PRODUCTS; ELASTOMERS; ENDOCRINOLOGY; SUSTAINABLE DEVELOPMENT;

BIS-PHENOL A; DOHAD; EDSP; FRAMEWORK FOR STRATEGIC SUSTAINABLE DEVELOPMENT (FSSD); TIPED;

ENDOCRINE DISRUPTERS;

EID: 84922455035     PISSN: 09596526     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclepro.2015.01.071     Document Type: Article

References (186)

1. Acevedo, N., Davis, B., Schaeberle, C.M., Sonnenschein, C., Soto, A.M., Perinatally administered bisphenol a as a potential mammary gland carcinogen in rats. Environ. Health Perspect. 121 (2013), 1040–1046.
2. Alonso-Magdalena, P., Ropero, A.B., Soriano, S., Garcia-Arevalo, M., Ripoll, C., Fuentes, E., Quesada, I., Nadal, A., Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol. Cell. Endocrinol. 355 (2012), 201–207.
3. Anand, P., Kunnumakkara, A.B., Sundaram, C., Harikumar, K.B., Tharakan, S.T., Lai, O.S., Sung, B., Aggarwal, B.B., Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 25 (2008), 2097–2116.
4. Attina, T.M., Trasande, L., Economic costs of childhood lead exposure in low- and middle-income countries. Environ. Health Perspect. 121 (2013), 1097–1102.
5. Barker, D.J.P., The developmental origins of adult disease. J. Am. Coll. Nutr. 23 (2004), 588S–595S.
6. Barker, D.J.P., Hanson, M.A., Altered regional blood flow in the fetus: the origins of cardiovascular disease?. Acta Paediatr. 93 (2004), 1559–1560.
7. Barker, D.J., Osmond, C., Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1 (1986), 1077–1081.
8. Barlow, S.M., Risk assessment of food-contact materials: past experience and future challenges. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 26 (2009), 1526–1533.
9. Barouki, R., Gluckman, P.D., Grandjean, P., Hanson, M., Heindel, J.J., Developmental origins of non-communicable disease: implications for research and public health. Environ. Health, 11, 2012, 42.
10. Bartlett, E.S., Trasande, L., Economic impacts of environmentally attributable childhood health outcomes in the European Union. Eur. J. Public Health 24 (2014), 21–26.
11. Basile, G., Broman, G., Robert, K.H., A systems-based strategic approach to sustainable enterprise: requirements, utility, and limits. McNall, S.G., Hershauser, J.C., Basile, G., (eds.) The Business of Sustainability: Trends, Policies, Practives, adn Stories of Success, 2011, ABC-CLIO, LLC, Santa Barbara, CA, 3–27.
12. Basketter, D., Ball, N., Cagen, S., Carrillo, J.-C., Certa, H., Eigler, D., Garcia, C., Esch, H., Graham, C., Haux, C., Kreiling, R., Mehling, A., Application of a weight of evidence approach to assessing discordant sensitisation datasets: implications for REACH. Regul. Toxicol. Pharmacol. 55 (2009), 90–96.
13. Baumgartner, R.J., Korhonen, J., Strategic thinking for sustainable development. Sustain. Dev. 18 (2010), 71–75.
14. Beausoleil, C., Ormsby, J.N., Gies, A., Hass, U., Heindel, J.J., Holmer, M.L., Nielsen, P.J., Munn, S., Schoenfelder, G., Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary. Chemosphere 93 (2013), 847–856.
15. Bergman, A., Andersson, A.M., Becher, G., van den Berg, M., Blumberg, B., Bjerregaard, P., Bornehag, C.G., Bornman, R., Brandt, I., Brian, J.V., Casey, S.C., Fowler, P.A., Frouin, H., Giudice, L.C., Iguchi, T., Hass, U., Jobling, S., Juul, A., Kidd, K.A., Kortenkamp, A., Lind, M., Martin, O.V., Muir, D., Ochieng, R., Olea, N., Norrgren, L., Ropstad, E., Ross, P.S., Ruden, C., Scheringer, M., Skakkebaek, N.E., Soder, O., Sonnenschein, C., Soto, A., Swan, S., Toppari, J., Tyler, C.R., Vandenberg, L.N., Vinggaard, A.M., Wiberg, K., Zoeller, R.T., Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors. Environ. Health, 12, 2013, 69.
16. Bergman, A., Heindel, J.J., Kasten, T., Kidd, K.A., Jobling, S., Neira, M., Zoeller, R.T., Becher, G., Bjerregaard, P., Bornman, R., Brandt, I., Kortenkamp, A., Muir, D., Drisse, M.N., Ochieng, R., Skakkebaek, N.E., Bylehn, A.S., Iguchi, T., Toppari, J., Woodruff, T.J., The impact of endocrine disruption: a consensus statement on the state of the science. Environ. Health Perspect. 121 (2013), A104–A106.
17. Bern, H.A., The fragile fetus. Colborn, T., Clement, C., (eds.) Chemically-induced Alterations in Sexual and Functional Development: the Wildlife/human Connection, 1992, Princeton Scientific Publishing Co., Inc., Princeton, 9–15.
18. Bertram, C.E., Hanson, M.A., Animal models and programming of the metabolic syndrome. Br. Med. Bull. 60 (2001), 103–121.
19. Betts, K.S., Tiered protocol for sussing out endocrine disruption. Environ. Health Perspect., 121, 2013, A16.
20. Birnbaum, L.S., Bucher, J.R., Collman, G.W., Zeldin, D.C., Johnson, A.F., Schug, T.T., Heindel, J.J., Consortium-based science: the NIEHS's multipronged, collaborative approach to assessing the health effects of Bisphenol A. Environ. Health Perspect. 120 (2012), 1640–1644.
21. Booth, F.W., Roberts, C.K., Laye, M.J., Lack of exercise is a major cause of chronic diseases. Compr. Physiol. 2 (2012), 1143–1211.
22. Borgert, C.J., Mihaich, E.M., Quill, T.F., Marty, M.S., Levine, S.L., Becker, R.A., Evaluation of EPA's tier 1 endocrine screening Battery and recommendations for improving the interpretation of screening results. Regul. Toxicol. Pharmacol. 59 (2011), 397–411.
23. Brennan, J., Norsk hydro ASA: sustainable PVC at hydro polymers?. Insead-eabis, 2008, INSEAD: The Business School for the World, France.
24. Burridge, E., Chemical profile: bisphenol A. ICIS Chem. Bus., 274, 2008, 48.
25. Calafat, A.M., Kuklenyik, Z., Reidy, J.A., Caudill, S.P., Tully, J.S., Needham, L.L., Serum concentrations of 11 polyfluoroalkyl compounds in the u.s. population: data from the national health and nutrition examination survey (NHANES). Environ. Sci. Technol. 41 (2007), 2237–2242.
26. Calafat, A.M., Ye, X., Wong, L.Y., Reidy, J.A., Needham, J.L., Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ. Health Perspect. 116 (2008), 39–44.
27. Cao, J., Rebuli, M.E., Rogers, J., Todd, K.L., Leyrer, S.M., Ferguson, S.A., Patisaul, H.B., Prenatal bisphenol a exposure alters sex-specific estrogen receptor expression in the neonatal rat hypothalamus and amygdala. Toxicol. Sci. 133 (2013), 157–173.
28. Carson, R., Silent Spring: 25th Anniversary Edition. 1987, Houghton Mifflin Co., New York.
29. Catanese, M.C., Suvorov, A., Vandenberg, L.N., Beyond a means of exposure: a new view of the mother in toxicology research. Toxicol. Res., 2015, 10.1039/C1034TX00119B (in press).
30. Chapin, R.E., Adams, J., Boekelheide, K., Gray, L.E. Jr., Hayward, S.W., Lees, P.S., McIntyre, B.S., Portier, K.M., Schnorr, T.M., Selevan, S.G., Vandenbergh, J.G., Woskie, S.R., NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res. B Dev. Reprod. Toxicol. 83 (2008), 157–395.
31. Christensen, F.M., Eisenreich, S.J., Rasmussen, K., Sintes, J.R., Sokull-Kluettgen, B., Van de Plassche, E.J., European experience in chemicals management: integrating science into policy. Environ. Sci. Technol. 45 (2011), 80–89.
32. Colborn, T., vom Saal, F.S., Soto, A.M., Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101 (1993), 378–384.
33. Colborn, T., Dumanoski, D., Myers, J.P., Our Stolen Future. 1995, Penguin Books, New York.
34. Collins, T.J., Introducing Green chemistry in teaching and research. J. Chem. Educ., 72, 1995, 965.
35. Collins, T., Toward sustainable chemistry. Science 291 (2001), 48–49.
36. Collins, T.J., Persuasive communication about matters of great urgency: endocrine disruption. Environ. Sci. Technol. 42 (2008), 7555–7558.
37. Cooper, R.L., Kavlock, R.J., Endocrine disruptors and reproductive development: a weight-of-evidence overview. J. Endocrinol. 152 (1997), 159–166.
38. Crain, D.A., Eriksen, M., Iguchi, T., Jobling, S., Laufer, H., LeBlanc, G.A., Guillette, L.J., An ecological assessment of bisphenol-A: evidence from comparative biology. Reprod. Toxicol. 24 (2007), 225–239.
39. Crain, D.A., Janssen, S.J., Edwards, T.M., Heindel, J.J., Ho, S.M., Hunt, P., Iguchi, T., Juul, A., McLachlan, J.A., Schwartz, J., Skakkebaek, N., Soto, A.M., Swan, S., Walker, C., Woodruff, T.K., Woodruff, T.J., Giudice, L.C., Guillette, L.J. Jr., Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil. Steril. 90 (2008), 911–940.
40. Delclos, K.B., Camacho, L., Lewis, S.M., Vanlandingham, M.M., Latendresse, J.R., Olson, G.R., Davis, K.J., Patton, R.E., da Costa, G.G., Woodling, K.A., Bryant, M.S., Chidambaram, M., Trbojevich, R., Juliar, B.E., Felton, R.P., Thorn, B.T., Toxicity evaluation of bisphenol A administered by gavage to Sprague Dawley rats from gestation day 6 through postnatal day 90. Toxicol. Sci. 139 (2014), 174–197.
41. Denver, R.J., Stress hormones mediate environment-genotype interactions during amphibian development. Gen. Comp. Endocrinol. 164 (2009), 20–31.
42. Diamanti-Kandarakis, E., Bourguignon, J.P., Guidice, L.C., Hauser, R., Prins, G.S., Soto, A.M., Zoeller, R.T., Gore, A.C., Endocrine-disrupting chemical: an endocrine society scientific statement. Endocr. Rev. 30 (2009), 293–342.
43. Echols, M.A., Food Safety and the WTO: the Interplay of Culture, Science and Technology. 2001, Kluwer Law International, Norwell, MA.
44. EDSTAC, Chapter Three: Conceptual Framework and Principles, EDSTAC Final Report., 1998.
45. EFSA, EFSA's 17th scientific colloquium on low dose response in toxicology and risk assessment. EFSA, (eds.) Scientific Colloquium Reports, Parma, Italy, 2012.
46. EFSA, Draft scientific opinion on the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs – exposure assessment. European Food Safety Authority, E, (eds.) EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids, Parma, Italy, 2013.
47. Ellis, W.C., Tran, C.T., Roy, R., Rusten, M., Fischer, A., Ryabov, A.D., Blumberg, B., Collins, T.J., Designing Green oxidation catalysts for purifying environmental waters. J. Am. Chem. Soc. 132 (2010), 9774–9781.
48. Entrala-Bueno, A., Iglesias, C., de Jesus, F., Diet and physical activity: a healthful binomial. Eur. J. Clin. Nutr. 57:Suppl. 1 (2003), S63–S65.
49. EPA, U., SAP Review of Weight of Evidence: Evaluating Results of EDSP Tier 1 Screening. 2013, US Environmental Protection Agency Endocrine Disruptor Screening Program.
50. EPA, U., Basics of Green Chemistry. 2014 http://www2.epa.gov/green-chemistry/basics-green-chemistry#twelve.
51. EPA, U., TSCA Chemical Substance Inventory. 2014 http://www.epa.gov/oppt/existingchemicals/pubs/tscainventory/basic.html.
52. Epstein, S.S., Reach: an unprecedented European initiative for regulating industrial chemicals. Int. J. Health Serv. 35 (2005), 1–38.
53. European Commission, European workshop on the impact of endocrine disrupters on human health and the environment. E.a.C.R., (eds.) Programme, 1997, DG XII, European Commission.
54. Even, M.D., Dhar, M.G., vom Saal, F.S., Transport of steroids between fetuses via amniotic fluid in relation to the intrauterine position phenomenon in rats. J. Reprod. Fertil. 96 (1992), 709–716.
55. FDA, U.S., Bisphenol a (BPA). 2008.
56. FDA, U.S., Endocrine Disruptor Knowledge Base. 2010 http://www.fda.gov/ScienceResearch/BioinformaticsTools/EndocrineDisruptorKnowledgebase/default.htm.
57. FDA, U.S., FDA, U.S., (eds.) Update on Bisphenol a for Use in Food Contact Applications, 2010 http://www.fda.gov/NewsEvents/PublicHealthFocus/ucm064437.htm.
58. Gee, D., Late lessons from early warnings: toward realism and precaution with endocrine-disrupting substances. Environ. Health Perspect. 114:Suppl. 1 (2006), 152–160.
59. Geens, T., Goeyens, L., Covaci, A., Are potential sources for human exposure to bisphenol-A overlooked?. Int. J. Hyg. Environ. Health 214 (2011), 339–347.
60. Geens, T., Aerts, D., Berthot, C., Bourguignon, J.P., Goeyens, L., Lecomte, P., Maghuin-Rogister, G., Pironnet, A.M., Pussemier, L., Scippo, M.L., Van Loco, J., Covaci, A., A review of dietary and non-dietary exposure to bisphenol-A. Food Chem. Toxicol. 50 (2012), 3725–3740.
61. Geens, T., Goeyens, L., Kannan, K., Neels, H., Covaci, A., Levels of bisphenol-A in thermal paper receipts from Belgium and estimation of human exposure. Sci. Total Environ. 435–436 (2012), 30–33.
62. Gerona, R.R., Woodruff, T.J., Dickenson, C.A., Pan, J., Schwartz, J.M., Sen, S., Friesen, M., Fujimoto, V.Y., Hunt, P.A., BPA, BPA glucuronide, and BPA sulfate in mid-gestation umbilical cord serum in a northern California cohort. Environ. Sci. Technol. 47 (2013), 12477–12485.
63. Gluckman, P.D., Hanson, M.A., Beedle, A.S., Early life events and their consequences for later disease: a life history and evolutionary perspective. Am. J. Hum. Biol. 19 (2007), 1–19.
64. Godfrey, K.M., Barker, D.J.P., Fetal programming and adult health. Public Health & Nutr. 4 (2004), 611–624.
65. Goodman, M., Squibb, K., Youngstrom, E., Anthony, L.G., Kenworthy, L., Lipkin, P.H., Mattison, D.R., Lakind, J.S., Using systematic reviews and meta-analyses to support regulatory decision making for neurotoxicants: lessons learned from a case study of PCBs. Environ. Health Perspect. 118 (2010), 727–734.
66. Gore, A.C., Heindel, J.J., Zoeller, R.T., Endocrine disruption for endocrinologists (and others). Endocrinology 147 (2006), S1–S3.
67. Gore, A.C., Balthazart, J., Bikle, D., Carpenter, D.O., Crews, D., Czernichow, P., Diamanti-Kandarakis, E., Dores, R.M., Grattan, D., Hof, P.R., Hollenberg, A.N., Lange, C., Lee, A.V., Levine, J.E., Millar, R.P., Nelson, R.J., Porta, M., Poth, M., Power, D.M., Prins, G.S., Ridgway, E.C., Rissman, E.F., Romijn, J.A., Sawchenko, P.E., Sly, P.D., Soder, O., Taylor, H.S., Tena-Sempere, M., Vaudry, H., Wallen, K., Wang, Z., Wartofsky, L., Watson, C.S., Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology 154 (2013), 3957–3960.
68. Grun, F., Blumberg, B., Endocrine disrupters as obesogens. Mol. Cell. Endocrinol. 304 (2009), 19–29.
69. Grun, F., Blumberg, B., Minireview: the case for obesogens. Mol. Endocrinol. 23 (2009), 1127–1134.
70. Hales, C.N., Barker, D.J., The thrifty phenotype hypothesis. Br. Med. Bull. 60 (2001), 5–20.
71. Hallstedt, S., Ny, H., Robèrt, K.-H., Broman, G., An approach to assessing sustainability integration in strategic decision systems for product development. J. Clean. Prod. 18 (2010), 703–712.
72. Hayes, T.B., There is no denying this: defusing the confusion about atrazine. BioScience 54 (2004), 1138–1149.
73. Hayes, T.B., Atrazine has been used safely for 50 years?. Elliott, J.E., Bishop, C.A., Morrissey, C.A., (eds.) Wildlife Ecotoxicology: Forensic Approaches, 2011, Spring Science + Business Media, LLC, New York, NY, 301–324.
74. Heindel, J.J., The fetal basis of adult disease: role of environmental exposures–introduction. Birth Defects Res. A Clin. Mol. Teratol. 73 (2005), 131–132.
75. Heindel, J.J., Vandenberg, L.N., Developmental origins of health and disease: a paradigm for understanding disease etiology and prevention. Curr. Opin. Pediatr., 2015, 10.1097/MOP.0000000000000191 (in press).
76. Herbst, A.L., Ulfelder, H., Poskanzer, D.C., Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284 (1971), 878–881.
77. Howard, G.J., Chemical alternatives assessment: the case of flame retardants. Chemosphere, 2014.
78. Hunt, P.A., Vandevoort, C.A., Woodruff, T., Gerona, R., Invalid controls undermine conclusions of FDA studies. Toxicol. Sci., 2014 pii: kfu100. ([Epub ahead of print]).
79. Ji, K., Hong, S., Kho, Y., Choi, K., Effects of bisphenol s exposure on endocrine functions and reproduction of zebrafish. Environ. Sci. Technol. 47 (2013), 8793–8800.
80. Kanno, J., Onyon, L., Haseman, J., Fenner-Crisp, P., Ashby, J., Owens, W., The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ. Health Perspect. 109 (2001), 785–794.
81. Kanno, J., Onyon, L., Peddada, S., Ashby, J., Jacob, E., Owens, W., The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies. Environ. Health Perspect. 111 (2003), 1550–1558.
82. Kanno, J., Onyon, L., Peddada, S., Ashby, J., Jacob, E., Owens, W., The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ. Health Perspect. 111 (2003), 1530–1549.
83. Kavlock, R.J., Daston, G.P., DeRosa, C., Fenner-Crisp, P., Gray, L.E., Kaattari, S., Lucier, G., Luster, M., Mac, M.J., Maczka, C., Miller, R., Moore, J., Rolland, R., Scott, G., Sheehan, D.M., Sinks, T., Tilson, H.A., Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 104 (1996), 715–740.
84. Khetan, S.K., Collins, T.J., Human pharmaceuticals in the aquatic environment: a challenge to green chemistry. Chem. Rev. 107 (2007), 2319–2364.
85. Kitamura, S., Suzuki, T., Sanoh, S., Kohta, R., Jinno, N., Sugihara, K., Yoshihara, S., Fujimoto, N., Watanabe, H., Ohta, S., Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol. Sci. 84 (2005), 249–259.
86. Klimisch, H.J., Andreae, M., Tillmann, U., A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol. 25 (1997), 1–5.
87. Koch, T., Denike, K., Rethinking John Snow's South London study: a Bayesian evaluation and recalculation. Soc. Sci. Med. 63 (2006), 271–283.
88. Kortenkamp, A., Martin, O., Faust, M., Evans, R., McKinlay, R., Orton, F., Rosivatz, E., State of the Art Assessment of Endocrine Disruptors Final Report., 2011, European Commission, Brussels, 442.
89. Kriebel, D., Tickner, J., Reenergizing public health through precaution. Am. J. Public Health 91 (2001), 1351–1355.
90. Kriebel, D., Tickner, J., Epstein, P., Lemons, J., Levins, R., Loechler, E.L., Quinn, M., Rudel, R., Schettler, T., Stoto, M., The precautionary principle in environmental science. Environ. Health Perspect. 109 (2001), 871–876.
91. Krimsky, S., Hormonal Chaos: the Scientific and Social Origins of the Environmental Endocrine Hypothesis. 2003, Johns Hopkins University Press, Baltimore, MD.
92. Kuruto-Niwa, R., Nozawa, R., Miyakoshi, T., Shiozawa, T., Terao, Y., Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Environ. Toxicol. Pharmacol. 19 (2005), 121–130.
93. Lamb, J.C.t., Boffetta, P., Foster, W.G., Goodman, J.E., Hentz, K.L., Rhomberg, L.R., Staveley, J., Swaen, G., Kraak, G.V., Williams, A.L., Critical comments on the WHO-UNEP state of the science of endocrine disrupting chemicals – 2012. Regul. Toxicol. Pharmacol. RTP, 2014.
94. Lanet, E., Maurange, C., Building a brain under nutritional restriction: insights on sparing and plasticity from Drosophila studies. Front. Physiol., 5, 2014, 117.
95. Liao, C., Liu, F., Alomirah, H., Loi, V.D., Mohd, M.A., Moon, H.B., Nakata, H., Kannan, K., Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ. Sci. Technol. 46 (2012), 6860–6866.
96. Liao, C., Liu, F., Guo, Y., Moon, H.B., Nakata, H., Wu, Q., Kannan, K., Occurrence of eight bisphenol analogues in indoor dust from the United States and several Asian countries: implications for human exposure. Environ. Sci. Technol. 46 (2012), 9138–9145.
97. Liao, C., Liu, F., Kannan, K., Bisphenol s, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol a residues. Environ. Sci. Technol. 46 (2012), 6515–6522.
98. Linkov, I., Loney, D., Cormier, S., Satterstrom, F.K., Bridges, T., Weight-of-evidence evaluation in environmental assessment: review of qualitative and quantitative approaches. Sci. Total Environ. 407 (2009), 5199–5205.
99. Maffini, M.V., Alger, H.M., Bongard, E.D., Neltner, T.G., Enhancing FDA's evaluation of science to ensure chemicals added to human food are safe: workshop proceedings. Comp. Rev. Food Sci. Food Saf. 10 (2011), 321–341.
100. Markey, C.M., Michaelson, C.L., Veson, E.C., Sonnenschein, C., Soto, A.M., The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ. Health Perspect. 109 (2001), 55–60.
101. Markey, C.M., Wadia, P.R., Rubin, B.S., Sonnenschein, C., Soto, A.M., Long-term effects of fetal exposure to low doses of the xenoestrogen bisphenol-A in the female mouse genital tract. Biol. Reproduction 72 (2005), 1344–1351.
102. Martinez Arias, A., Nichols, J., Schroter, C., A molecular basis for developmental plasticity in early mammalian embryos. Development 140 (2013), 3499–3510.
103. Mathew, M., Sreedhanya, S., Manoj, P., Aravindakumar, C.T., Aravind, U.K., Exploring the interaction of bisphenol-s with serum albumins: a better or worse alternative for bisphenol a?. J. Phys. Chem. B 118 (2014), 3832–3843.
104. McLachlan, J.A., Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr. Rev. 22 (2001), 319–341.
105. McLachlan, J.A., Commentary: prenatal exposure to diethylstilbestrol (DES): a continuing story. Int. J. Epidemiol. 35 (2006), 868–870.
106. Michaels, D., Doubt is their product. Sci. Am. 292 (2005), 96–101.
107. Michaels, D., Manufactured uncertainty: protecting public health in the age of contested science and product defense. Ann. N. Y. Acad. Sci. 1076 (2006), 149–162.
108. Molina-Molina, J.M., Amaya, E., Grimaldi, M., Saenz, J.M., Real, M., Fernandez, M.F., Balaguer, P., Olea, N., In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. Toxicol. Appl. Pharmacol., 2013.
109. Myers, J.P., vomsaal, F.S., Akingbemi, B.T., Arizono, K., Belcher, S., Colborn, T., Chahoud, I., Crain, D.A., Farabollini, F., Guillette, L.J., Hassold, T., Ho, S.-M., Hunt, P.A., Iguchi, T., Jobling, S., Kanno, J., Laufer, H., Marcus, M., McLachlan, J.A., Nadal, A., Oehlmann, J., Olea, N., Palanza, P., Parmigiani, S., Rubin, B.S., Schonfelder, G., Sonnenschein, C., Soto, A.M., Talsness, C.E., Taylor, J.A., Vandenberg, L.N., Vandenbergh, J.G., Vogel, S., Watson, C.S., Welshons, W.V., Zoeller, R.T., Why public health agencies cannot depend upon 'Good Laboratory Practices' as a criterion for selecting data: the case of bisphenol-A. Environ. Health Perspect. 117 (2009), 309–315.
110. Myers, J.P., Zoeller, R.T., vom Saal, F.S., A clash of old and new scientific concepts in toxicity, with important implications for public health. Environ. Health Perspect. 117 (2009), 1652–1655.
111. Naderi, M., Wong, M.Y., Gholami, F., Developmental exposure of zebrafish (Danio rerio) to bisphenol-S impairs subsequent reproduction potential and hormonal balance in adults. Aquat. Toxicol. 148 (2014), 195–203.
112. Needham, L.L., Calafat, A.M., Barr, D.B., Assessing developmental toxicant exposures via biomonitoring. Basic Clin. Pharmacol. Toxicol. 102 (2008), 100–108.
113. Neltner, T.G., Alger, H.M., Leonard, J.E., Maffini, M.V., Data gaps in toxicity testing of chemicals allowed in food in the United States. Reprod. Toxicol. 42 (2013), 85–94.
114. Neltner, T.G., Alger, H.M., O'Reilly, J.T., Krimsky, S., Bero, L.A., Maffini, M.V., Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. JAMA Intern Med. 173 (2013), 2032–2036.
115. Newbold, R.R., Lessons learned from perinatal exposure to diethylstilbestrol. Toxicol. Appl. Pharmacol. 199 (2004), 142–150.
116. OECD, Uterotrophic bioassay in rodents: a short-term screening test for oestrogenic properties. OECD/OCDE, (eds.) OECD Guideline for the Testing of Chemicals, 2007, 440.
117. Ozanne, S.E., Metabolic programming in animals. Br. Med. Bull. 60 (2001), 143–152.
118. Patisaul, H.B., Roberts, S.C., Mabrey, N., McCaffrey, K.A., Gear, R.B., Braun, J., Belcher, S.M., Stapleton, H.M., Accumulation and endocrine disrupting effects of the flame retardant mixture Firemaster((R)) 550 in rats: an exploratory assessment. J. Biochem. Mol. Toxicol. 27 (2013), 124–136.
119. PBS, Fooling with Nature; Interview: Theo Colborn, PhD. 2007.
120. Peretz, J., Vrooman, L., Ricke, W.A., Hunt, P.A., Ehrlich, S., Hauser, R., Padmanabhan, V., Taylor, H.S., Swan, S.H., VandeVoort, C.A., Flaws, J.A., Bisphenol a and reproductive health: update of experimental and human evidence, 2007–2013. Environ. Health Perspect. 122 (2014), 775–786.
121. Rebuli, M.E., Cao, J., Sluzas, E., Delclos, K.B., Camacho, L., Lewis, S.M., Vanlandingham, M.M., Patisaul, H.B., Investigation of the effects of subchronic low dose oral exposure to bisphenol A (BPA) and ethinyl estradiol (EE) on estrogen receptor expression in the juvenile and adult female rat hypothalamus. Toxicol. Sci. 140 (2014), 190–203.
122. Reif, D.M., Martin, M.T., Tan, S.W., Houck, K.A., Judson, R.S., Richard, A.M., Knudsen, T.B., Dix, D.J., Kavlock, R.J., Endocrine profiling and prioritization of environmental chemicals using ToxCast data. Environ. Health Perspect. 118 (2010), 1714–1720.
123. Rhomberg, L.R., Goodman, J.E., Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made?. Regul. Toxicol. Pharmacol. 64 (2012), 130–133.
124. Rhomberg, L.R., Goodman, J.E., Foster, W.G., Borgert, C.J., Van Der Kraak, G., A critique of the European commission document, “State of the art assessment of endocrine Disrupters”. Crit. Rev. Toxicol. 42 (2012), 465–473.
125. Richter, C., Birnbaum, L.S., Farabollini, F., Newbold, R.R., Rubin, B.S., Talsness, C.E., Vandenbergh, J.G., Walser-Kuntz, D.R., vom Saal, F.S., In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 24 (2007), 199–224.
126. Robèrt, K.H., Schmidt-Bleek, B., Aloisi de Larderel, J., Basile, G., Jansen, J.L., Kuehr, R., Price Thomas, P., Suzuki, M., Hawken, P., Wackernagel, M., Strategic sustainable development — selection, design and synergies of applied tools. J. Clean. Prod. 10 (2002), 197–214.
127. Robèrt, K.-H., Broman, G.I., Basile, G., Analyzing the concept of planetary Boundaries from a strategic sustainability perspective: how does humanity avoid tipping the planet?. Ecol. Soc., 18, 2013.
128. Rochester, J.R., Bisphenol A and human health: a review of the literature. Reprod. Toxicol. 42C (2013), 132–155.
129. Rosenberg, E.I., Bass, P.F. 3rd, Davidson, R.A., Arriving at correct conclusions: the importance of association, causality, and clinical significance. South Med. J. 105 (2012), 161–166.
130. Rosenmai, A.K., Dybdahl, M., Pedersen, M., Alice van Vugt-Lussenburg, B.M., Wedebye, E.B., Taxvig, C., Vinggaard, A.M., Are structural analogues to bisphenol a safe alternatives?. Toxicol. Sci. 139 (2014), 35–47.
131. Ryan, B.C., Vandenbergh, J.G., Intrauterine position effects. Neurosci. Biobehav. Rev. 26 (2002), 665–678.
132. Sadrian, B., Wilson, D.A., Saito, M., Long-lasting neural circuit dysfunction following developmental ethanol exposure. Brain Sci. 3 (2013), 704–727.
133. Sakata, J.T., Crews, D., Developmental sculpting of social phenotype and plasticity. Neurosci. Biobehav Rev. 28 (2004), 95–112.
134. Schreider, J., Barrow, C., Birchfield, N., Dearfield, K., Devlin, D., Henry, S., Kramer, M., Schappelle, S., Solomon, K., Weed, D.L., Embry, M.R., Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative. Toxicol. Sci. 116 (2010), 5–7.
135. Schug, T.T., Janesick, A., Blumberg, B., Heindel, J.J., Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 127 (2011), 204–215.
136. Schug, T.T., Abagyan, R., Blumberg, B., Collins, T.J., Crews, D., DeFur, P.L., Dickerson, S.M., Edwards, T.M., Gore, A.C., Guillette, L.J., Hayes, T., Heindel, J.J., Moores, A., Patisaul, H.B., Tal, T.L., Thayer, K.A., Vandenberg, L.N., Warner, J.C., Watson, C.S., Vom Saal, F.S., Zoeller, R.T., O'Brien, K.P., Myers, J.P., Designing endocrine disruption out of the next generation of chemicals. Green. Chem. 15 (2013), 181–198.
137. Shappell, N.W., Vrabel, M.A., Madsen, P.J., Harrington, G., Billey, L.O., Hakk, H., Larsen, G.L., Beach, E.S., Horwitz, C.P., Ro, K., Hunt, P.G., Collins, T.J., Destruction of estrogens using Fe-TAML/Peroxide catalysis. Environ. Sci. Technol. 42 (2008), 1296–1300.
138. Sheehan, D.M., No-threshold dose-response curves for nongenotoxic chemicals: findings and application for risk assessment. Environ. Res. 100 (2006), 93–99.
139. Skinner, M.K., Manikkam, M., Guerrero-Bosagna, C., Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol. Metab. 21 (2010), 214–222.
140. Soto, A.M., Vandenberg, L.N., Maffini, M.V., Sonnenschein, C., Does breast cancer start in the womb?. Basic Clin. Pharmacol. Toxicol. 102 (2008), 125–133.
141. Soto, A.M., Brisken, C., Schaeberle, C., Sonnenschein, C., Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J. Mammary Gland. Biol. Neoplasia 18 (2013), 199–208.
142. US Government Accounting Office, Toxic Substances Control Act: EPA's Limited Progress in Regulating Toxic Chemicals. 1994 Available from: http://archive.gao.gov/t2pbat3/151661.pdf.
143. Trasande, L., Further limiting bisphenol a in food uses could provide health and economic benefits. Health Aff. (Millwood) 33 (2014), 316–323.
144. Trasande, L., Liu, Y., Reducing the staggering costs of environmental disease in children, estimated at $76.6 billion in 2008. Health Aff. 30 (2011), 863–870.
145. Tyl, R.W., Basic exploratory research versus guideline-compliant studies used for hazard evaluation and risk assessment: bisphenol A as a case study. Environ. Health Perspect. 117 (2009), 1644–1651.
146. Tyl, R.W., In honor of the teratology Society's 50th anniversary: the role of teratology society members in the development and evolution of in vivo developmental toxicity test guidelines. Birth Defects Res. Part. C. 90 (2010), 99–102.
147. Tyl, R.W., Myers, C.B., Marr, M.C., Sloan, C.S., Castillo, N.P., Veselica, M.M., Seely, J.C., Dimond, S.S., Van Miller, J.P., Shiotsuka, R.N., Beyer, D., Hentges, S.G., Waechter, J.M. Jr., Two-generation reproductive toxicity study of dietary bisphenol A in CD-1 (Swiss) mice. Toxicol. Sci. 104 (2008), 362–384.
148. Vandenberg, L.N., Exposure to bisphenol A in Canada: invoking the precautionary principle. CMAJ 183 (2011), 1265–1270.
149. Vandenberg, L.N., Bisphenol a and aging. Weiss, B., (eds.) Aging and Vulnerability to Environmental Chemicals: Age-related Disorders and Their Origins in Environmental Exposures, 2013, Royal Society of Chemistry, London, 241–266.
150. Vandenberg, L.N., Hauser, R., Marcus, M., Olea, N., Welshons, W.V., Human exposure to bisphenol A (BPA). Reprod. Toxicol. 24 (2007), 139–177.
151. Vandenberg, L.N., Maffini, M.V., Sonnenschein, C., Rubin, B.S., Soto, A.M., Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 30 (2009), 75–95.
152. Vandenberg, L.N., Chahoud, I., Heindel, J.J., Padmanabhan, V., Paumgartten, F.J.R., Schoenfelder, G., Urine, serum and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 118 (2010), 1055–1070.
153. Vandenberg, L.N., Colborn, T., Hayes, T.B., Heindel, J.J., Jacobs, D.R. Jr., Lee, D.H., Shioda, T., Soto, A.M., vom Saal, F.S., Welshons, W.V., Zoeller, R.T., Myers, J.P., Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 33 (2012), 378–455.
154. Vandenberg, L.N., Colborn, T., Hayes, T.B., Heindel, J.J., Jacobs, D.R., Lee, D.H., Myers, J.P., Shioda, T., Soto, A.M., Vom Saal, F.S., Welshons, W.V., Zoeller, R.T., Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod. Toxicol. 38C (2013), 1–15.
155. Vandenberg, L.N., Ehrlich, S., Belcher, S.M., Ben-Jonathan, N., Dolinoy, D.C., Hugo, E.R., Hunt, P.A., Newbold, R.R., Rubin, B.S., Saili, K.S., Soto, A.M., Wang, H.S., Vom Saal, F.S., Low dose effects of Bisphenol A: an integrated review of in vitro, laboratory animal and epidemiology studies. Endocr. Disrupt., 1, 2013, e25078.
156. Vandenberg, L.N., Hunt, P.A., Myers, J.P., Vom Saal, F.S., Human exposures to bisphenol A: mismatches between data and assumptions. Rev. Environ. Health 28 (2013), 37–58.
157. Vandenberg, L.N., Gerona, R.R., Kannan, K., Taylor, J.A., Van Breemen, R.B., Dickenson, C.A., Liao, C., Yuan, Y., Newbold, R.R., Padmanabhan, V., Vom Saal, F.S., Woodruff, T.J., A round robin approach to the analysis of bisphenol A (BPA) in human blood samples. Environ. Health, 13, 2014, 25.
158. Vandenberg, L.N., Welshons, W.V., Vom Saal, F.S., Toutain, P.L., Myers, J.P., Should oral gavage be abandoned in toxicity testing of endocrine disruptors?. Environ. Health, 13, 2014, 46.
159. Vinas, P., Watson, C.S., Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ. Health Perspect. 121 (2013), 352–358.
160. Vinas, P., Campillo, N., Martinez-Castillo, N., Hernandez-Cordoba, M., Comparison of two derivatization-based methods for solid-phase microextraction-gas chromatography-mass spectrometric determination of bisphenol A, bisphenol S and biphenol migrated from food cans. Anal. Bioanal. Chem. 397 (2010), 115–125.
161. vom Saal, F.S., Dhar, M.G., Blood flow in the uterine loop artery and loop vein is bidirectional in the mouse: implications for transport of steroids between fetuses. Physiol. Behav. 52 (1992), 163–171.
162. vom Saal, F.S., Hughes, C., An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 113 (2005), 926–933.
163. vom Saal, F.S., Myers, J.P., Good laboratory practices are not synonymous with good scientific practices, accurate reporting, or valid data. Environ. Health Perspect., 118, 2010, A60.
164. vom Saal, F.S., Sheehan, D.M., Challenging risk assessment. Forum Appl. Res. Public Policy 13 (1998), 11–18.
165. vom Saal, F.S., Welshons, W.V., Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ. Res. 100 (2006), 50–76.
166. vom Saal, F.S., Even, M.D., Quadagno, D.M., Effects of maternal stress on puberty, fertility and aggressive behavior of female mice from different intrauterine positions. Physiol. Behav. 49 (1991), 1073–1078.
167. vom Saal, F.S., Cooke, P.S., Buchanan, D.L., Palanza, P., Thayer, K.A., Nagel, S.C., Parmigiani, S., Welshons, W.V., A physiologically based approach to the study of bisphenol A and other estrogenic chemicals on the size of reproductive organs, daily sperm production, and behavior. Toxicol. Ind. Health 14 (1998), 239–260.
168. vom Saal, F.S., Richter, C.A., Ruhlen, R.R., Nagel, S.C., Timms, B.G., Welshons, W.V., The importance of appropriate controls, animal feed, and animal models in interpreting results from low-dose studies of bisphenol A. Birth Defects Res. Part. A) 73 (2005), 140–145.
169. vom Saal, F.S., Akingbemi, B.T., Belcher, S.M., Birnbaum, L.S., Crain, D.A., Eriksen, M., Farabollini, F., Guillette, L.J. Jr., Hauser, R., Heindel, J.J., Ho, S.M., Hunt, P.A., Iguchi, T., Jobling, S., Kanno, J., Keri, R.A., Knudsen, K.E., Laufer, H., LeBlanc, G.A., Marcus, M., McLachlan, J.A., Myers, J.P., Nadal, A., Newbold, R.R., Olea, N., Prins, G.S., Richter, C.A., Rubin, B.S., Sonnenschein, C., Soto, A.M., Talsness, C.E., Vandenbergh, J.G., Vandenberg, L.N., Walser-Kuntz, D.R., Watson, C.S., Welshons, W.V., Wetherill, Y., Zoeller, R.T., Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod. Toxicol. 24 (2007), 131–138.
170. vom Saal, F.S., Akingbemi, B.T., Belcher, S.M., Crain, D.A., Crews, D., Guidice, L.C., Hunt, P.A., Leranth, C., Myers, J.P., Nadal, A., Olea, N., Padmanabhan, V., Rosenfeld, C.S., Schneyer, A., Schoenfelder, G., Sonnenschein, C., Soto, A.M., Stahlhut, R.W., Swan, S.H., Vandenberg, L.N., Wang, H.S., Watson, C.S., Welshons, W.V., Zoeller, R.T., Flawed experimental design reveals the need for guidelines requiring appropriate positive controls in endocrine disruption research. Toxicol. Sci. 115 (2010), 612–613.
171. vom Saal, F.S., Vandervoort, C., Taylor, J.A., Welshons, W.V., Toutain, P.L., Hunt, P.A., Bisphenol A (BPA) pharmacokinetics with daily oral bolus or continuous exposure via silastic capsules in pregnant Rhesus monkeys: relevance for human exposures. Reprod. Toxicol. 45 (2014), 105–116.
172. Walker, D.M., Gore, A.C., Transgenerational neuroendocrine disruption of reproduction. Nat. Rev. Endocrinol. 7 (2011), 197–207.
173. Weed, D.L., Weight of evidence: a review of concepts and methods. Risk Anal. 25 (2005), 1545–1557.
174. Weinhouse, C., Anderson, O.S., Bergin, I.L., Vandenbergh, D.J., Gyekis, J.P., Dingman, M.A., Yang, J., Dolinoy, D.C., Dose-dependent incidence of hepatic tumors in adult mice following perinatal exposure to bisphenol A. Environ. Health Perspect. 122 (2014), 485–491.
175. Weiss, B., Neurobehavioral toxicity as a basis for risk assessment. Trends Pharmacol. Sci. 9 (1988), 59–62.
176. Weiss, B., Anogenital distance: defining “normal”. Environ. Health Perspect., 114, 2006, A399 author reply A399.
177. Welshons, W.V., Thayer, K.A., Judy, B.M., Taylor, J.A., Curran, E.M., vom Saal, F.S., Large effects from small exposures: I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ. Health Perspect. 111 (2003), 994–1006.
178. Western, P.S., Sinclair, A.H., Sex, genes, and heat: triggers of diversity. J. Exp. Zool. 290 (2001), 624–631.
179. Wetherill, Y.B., Akingbemi, B.T., Kanno, J., McLachlan, J.A., Nadal, A., Sonnenschein, C., Watson, C.S., Zoeller, R.T., Belcher, S.M., In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. 24 (2007), 178–198.
180. WHO, State of the science of endocrine disrupting chemicals – 2012. WHO/UNEP, (eds.) An Assessment of the State of the Science of Endocrine Disruptors Prepared by a Group of Experts for the United Nations Environment Programme (UNEP) and WHO, 2013.
181. Wingspread Participants, Wingspread consensus statement. Colborn, T., Clement, C., (eds.) Chemically Induced Alterations in Sexual and Functional Development: the Human/wildlife Connection, 1992, Princeton Scientific Publishing, Princeton, 1–8.
182. Woodruff, T.J., Sutton, P., An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Aff. 30 (2011), 931–937.
183. Woodruff, T.J., Zeise, L., Axelrad, D.A., Guyton, K.Z., Janssen, S., Miller, M., Miller, G.G., Schwartz, J.M., Alexeeff, G., Anderson, H., Birnbaum, L., Bois, F., Cogliano, V.J., Crofton, K., Euling, S.Y., Foster, P.M., Germolec, D.R., Gray, E., Hattis, D.B., Kyle, A.D., Luebke, R.W., Luster, M.I., Portier, C., Rice, D.C., Solomon, G., Vandenberg, J., Zoeller, R.T., Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making. Environ. Health Perspect. 116 (2008), 1568–1575.
184. Woodruff, T.J., Zota, A.R., Schwartz, J.M., Environmental chemicals in pregnant women in the US: NHANES 2003–2004. Environ. Health Perspect. 119 (2011), 878–885.
185. Zoeller, R.T., Brown, T.R., Doan, L.L., Gore, A.C., Skakkebaek, N.E., Soto, A.M., Woodruff, T.J., Vom Saal, F.S., Endocrine-disrupting chemicals and public health protection: a statement of principles from the endocrine Society. Endocrinology 153 (2012), 4097–4110.
186. Zoeller, R.T., Bergman, A., Becher, G., Bjerregaard, P., Bornman, R., Brandt, I., Iguchi, T., Jobling, S., Kidd, K.A., Kortenkamp, A., Skakkebaek, N.E., Toppari, J., Vandenberg, L.N., A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ. Health, 13, 2014, 118.